Glaxosmithkline Pharmaceuticals Ltd
company logo

Glaxosmithkline Pharmaceuticals Ltd

Pharmaceuticals
Large Cap

-

- (0%)


Glaxosmithkline Pharmaceuticals Ltd Performance

-

-

-

-


-

-

-

-

-

Glaxosmithkline Pharmaceuticals Ltd Fundamentals

43,551.75Cr

66.33

24.50

0.01

38.76

1.24%

104.93

i buttonClick here to know more about Fundamentals

Glaxosmithkline Pharmaceuticals Ltd Financials

Glaxosmithkline Pharmaceuticals Ltd Financialsright-arrow

Glaxosmithkline Pharmaceuticals Ltd Shareholding Pattern

Glaxosmithkline Pharmaceuticals Ltd Delivery and Volume

About Glaxosmithkline Pharmaceuticals Ltd

GlaxoSmithKline Pharmaceuticals Limited is a subsidiary of UK-based GSK Plc., a global biopharma company to unite science, technology and talent to get ahead of disease together. The Company is headquartered in Mumbai and it has six branch offices, a manufacturing facility at Nashik in Maharashtra,

Bhushan Akshikar

1924

GLAXO

NameDesignation
D SundaramIndependent Director
A A NadkarniCompany Sec. & Compli. Officer
P V BhideIndependent Director
A N RoyIndependent Director
Subesh WilliamsNon Executive Director
Renu S KarnadChairperson
Sunita MaheshwariIndependent Director
Manu AnandIndependent Director
Bhushan AkshikarManaging Director
J. ChandyWhole Time Director & CFO
News and Events...

Similar Stocks

What's Trending

Glaxosmithkline Pharmaceuticals Ltd FAQs

By opening a demat account and having your KYC papers confirmed online, you may simply purchase Glaxosmithkline Pharmaceuticals Ltd shares in BlinkX.
The share price of any stock is volatile and changes during the day due to a variety of variables. Glaxosmithkline Pharmaceuticals Ltd's share price is ₹2570.7 as of 2024-07-13.
Glaxosmithkline Pharmaceuticals Ltd's P/E ratio is 66.33 times as of 2024-07-13.
Glaxosmithkline Pharmaceuticals Ltd's most recent financial reports indicate a price-to-book ratio of 24.5, showing the company's stock market valuation in relation to the value of its real assets.
Market capitalization, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Glaxosmithkline Pharmaceuticals Ltd's market capitalization is ₹43551.75 Cr as on 2024-07-13.
The current financial records of Glaxosmithkline Pharmaceuticals Ltd show a 36.83% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.
According to Glaxosmithkline Pharmaceuticals Ltd's most recent financial filings, the company has a total asset value of ₹2115.7, which includes current and non-current assets such as inventory, cash, properties, and equipment.
The 52-week high/low price of a Glaxosmithkline Pharmaceuticals Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Glaxosmithkline Pharmaceuticals Ltd's 52-week high and low as of 2024-07-13 are ₹2619.9 and ₹2540.6, respectively.